Article

Production of Lipid-Nanoparticles mRNA Lung Cancer Vaccine and Neutralizing Monoclonal Antibodies to Mutated Forms of KRAS Antigens

2025-06-04

Abstract excerpt

<h4>Background: </h4> Tumour invasion is caused by mutations in the KRAS gene, and lung cancer is one of the world's leading causes of death. Aim of the study: To create monoclonal antibodies against the KRAS protein mutation in lung cancer and to produce a lipid-nanoparticle (LNP)-mRNA vaccine against various lung cancer types. Type of the study: Screening experimental study. Methodology: Using hybridoma tec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b405d7fc-a2da-531d-bc4f-55ff6f3525ef
DOI: 10.20944/preprints202506.0013.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Production of Lipid-Nanoparticles mRNA Lung Cancer Vaccine and Neutralizing Monoclonal Antibodies to Mutated Forms of KRAS AntigensDOI 10.20944/preprints202506.0013.v1Read

Bioinformatics, Molecular Docking analysis and Cell Culture Testing of Mutated p53 and Overexpressed CEA in Lung Cancer for mRNA Vaccine DevelopmentSemantic proximity Read

A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation.Semantic proximity Read

Micellar co-delivery of KRAS-mutant inhibitors and TLR7/8 agonists synergizes targeted therapy and immunotherapy in lung cancer.Semantic proximity Read

Polymer-lipid hybrid nanoparticle enhances mRNA delivery and T cell-mediated immunitySemantic proximity Read

Lung-targeted cytokine-coding RNA-lipoplexes induce T and NK cell-mediated anti-tumor immune responseSemantic proximity Read

From structural design to delivery: mRNA therapeutics for cancer immunotherapySemantic proximity Read

Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer.Semantic proximity Read

Targeted delivery of metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid Nano-assembliesSemantic proximity Read

Second generation of LNP based mRNA vaccine leads to a T cell–inflamed tumor microenvironment favorable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumor modelSemantic proximity Read

Nanoparticle-mediated mRNA delivery to TNBC PDX tumorsSemantic proximity Read

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapySemantic proximity Read

DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model.Semantic proximity Read